基本情報
- 標準SMILES
CNCC(O)c1ccc(O)cc1- InChIKey
YRCWQPVGYLYSOX-UHFFFAOYSA-N- 分子式
- C9H13NO2
- 平均分子量
- 167.2 g/mol
- 単同位体質量
- 167.09462866
概要
Synephrine is a phenethylamine alkaloid that is 4-(2-aminoethyl)phenol substituted by a hydroxy group at position 1 and a methyl group at the amino nitrogen. It has a role as an alpha-adrenergic agonist and a plant metabolite. It is a member of ethanolamines, a member of phenols and a phenethylamine alkaloid. It is a conjugate base of a synephrinium.
名称と識別子
- 優先名称
- Synephrine
- IUPAC
- 4-[1-hydroxy-2-(methylamino)ethyl]phenol
名称と別名
名称をさらに表示
データベース識別子
- CAS
94-07-5- PubChem CID
- 7172
- DTXSID
DTXSID0030588- ChEMBL
CHEMBL33720- ChEBI
CHEBI:29081- UNII
- PEG5DP7434
- EC Number
- 202-300-9
- Nikkaji
- J8.617G
物性
構造計算による物性
- XLogP
- -0.6
- 極性表面積
- 52.5 Ų
- 水素結合供与体数
- 3
- 水素結合受容体数
- 3
- 回転可能結合数
- 3
- 重原子数
- 12
- 形式電荷
- 0
- 複雑度
- 122
実験および物理化学的性質
LogP
-0.45
-0.45
Collision Cross Section
241.8 Ų [M+H]+ [CCS Type: DT; Buffer gas: N2; Ionization: ESI+; Dataset: TOXCAST; Source Identifier: DTXSID0030588]
130.49 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
132 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
134.4 Ų [M+H-H2O]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]
安全と法規制
GHS分類
GHS Classification
Warning
H315 (97.8%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 45 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
危険有害性情報
化学と産業
薬理情報
ATC Code
C - Cardiovascular system
S - Sensory organs
QC - Cardiovascular system
QS - Sensory organs
QS - Sensory organs
MeSH Pharmacological Classification
Drugs that selectively bind to and activate alpha adrenergic receptors.
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.
Drugs used to cause constriction of the blood vessels.
Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993)
関連反応
関連ノート
読み込み中…